Donate now
Hadassah Australia
  • Hadassah Australia
  • Hadassah Belgium
  • Hadassah Brasil
  • Canadian Hadassah-WIZO
  • Hadassah France
  • Hadassah Germany
  • Hadassah International
  • Hadassah International Israel
  • Hadassah Latinoamerica
  • Hadassah New Zealand
  • Hadassah Panama
  • Hadassah Switzerland
  • Hadassah United Kingdom
  • Hadassah USA
  • Hadassah Medical Center - Israel -- all languages
  • Hadassah Medical Center- Israel – English only

Hadassah International

Hadassah International

Hadassah International Supports the Hadassah Medical Center: More than a Hospital!


  • Home
  • Who we are
    • Hadassah International
    • Hadassah Medical Organization
    • What Hadassah Means To Me
    • History
    • Conference
  • Where we are
    • Our International Network and Websites
    • Hadassah USA
    • Our Mission in Action
    • Contact Us
  • Ukraine Emergency
  • News
  • Make the difference
  • How you can help
    • Support our projects
    • Wills and Bequests
  • Video Gallery
  • Subscribe
  • Podcasts

Hadassah and MyBiotics Join Forces to Improve Cancer Immunotherapy

Hadassah and MyBiotics Join Forces to Improve Cancer Immunotherapy

MyBiotics Pharma Ltd., a microbiome therapeutics company, and Hadasit, the Hadassah Medical Organization’s technology transfer company, have entered into a collaboration and licensing agreement for the identification of microbiome-based therapies…

Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Pin on Pinterest
Pinterest
Email this to someone
email

Hadasit

First-Ever International Lifetime Achievement Award Goes to Hadassah Psychiatrist

...More than a Hospital

First in Israel: Hadasit Launches Medical Startup Accelerator with IBM

ALS Research

Hadassah and Kadimastem Co-Design Embryonic Stem Cell Protocol for ALS Clinical Trial

Graft vs Host disease

Hadasit and Cellect Team Up for Stem Cell Innovation

Research

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Drugs and Antibiotics

Collaboration Announced to Develop Hadassah Drug to Treat “Untreatable” NASH Liver Disease

Research

HMO and Hebrew U Students Invent Device to Save Terror Victims

Research

BioDesign Hadassah-Hebrew University Team Invents Solution to Surgical Problem

Cardiology Research

Hadassah-Developed Imaging Agent to Begin Clinical Trials with Multi-million Euro Grant

Liver Disease

Hadassah Drug to Fight Fatty Liver Disease Progressing Well in US Clinical Trials

Liver Research

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Cardiology Research

Hadasit Sets Up Incubator Company to Develop Stent Locator

Liver Research

Hadassah Researchers Identify Connection Between Natural Killer Cell and Cirrhosis

Cancer Research

New Test Developed at Hadassah Predicts Presence of Harmful BRCA Mutation Which Can Trigger Breast Cancer

Cardiology

Hadasit Sets Up Incubator Company to Develop Stent Locator

Bone-marrow (transplantation)

Enlivex Successfully Completes First Trial for Treatment of Graft-Versus-Host Disease (GVHD)

Hematology

Hadassah Researchers Develop Animal-Component Free, Human Embryonic Stem Cell Lines, Suitable for Human Transplantation

Hadasit

Thrombotech Receives Regulatory Approval for Stroke Medicine Trials in the US

Building Bridges to Peace

Hadasit Launches New Jewish-Arab Biomedical Community Initiative

  • ← Older posts
  • Home
  • Who we are
  • News
  • Donate now
  • Year in Review
  • Contact Us
  • Terms and Conditions
  • Hadassah International Newsletters
  • Pamphlets / Downloads
  • Podcasts
  • Hadassah International Privacy and Cookie Policy Statement

© 2022 Hadassah International, Ltd. Hadassah, the H logo, the Hadassah International logo, and Hadassah the Power of Women Who Do are registered trademarks of Hadassah, The Women’s Zionist Organization of America, Inc.